NovaBridge Biosciences Current Assets
NovaBridge Biosciences (NBP) had Current Assets of $217.52 million as of 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-04-07
- 2023-12-31: Assets, Current 2.34B CNY.
- 2022-12-31: Assets, Current 3.63B CNY.
- 2022-06-30: Assets, Current 4.31B CNY.
- 2021-12-31: Assets, Current 4.78B CNY.
CNY
| Period end | Assets, Current |
|---|---|
| 2023-12-31 | 2.34B CNY 20-F · filed 2024-04-30 |
| 2022-12-31 | 3.63B CNY 20-F · filed 2024-04-30 |
| 2022-06-30 | 4.31B CNY 6-K · filed 2022-11-10 |
| 2021-12-31 | 4.78B CNY 20-F · filed 2023-05-01 |
| 2020-12-31 | 5.34B CNY 20-F · filed 2022-04-29 |
| 2020-09-30 | 3.21B CNY 6-K · filed 2021-02-05 |
| 2019-12-31 | 1.36B CNY 20-F · filed 2021-04-28 |
| 2018-12-31 | 2.04B CNY 20-F · filed 2020-04-29 |
USD
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $217.52M 20-F · filed 2026-04-07 | |
| 2025-09-30 | $232.78M 6-K · filed 2025-12-18 | |
| 2025-06-30 | $167.64M 6-K · filed 2025-10-06 | |
| 2024-12-31 | $176.69M 20-F · filed 2026-04-07 | |
| 2023-12-31 | $329.91M 20-F · filed 2025-04-03 | $329.11M 20-F · filed 2024-04-30 |
| 2022-12-31 | $525.79M 20-F · filed 2023-05-01 | |
| 2022-06-30 | $644.16M 6-K · filed 2022-11-10 | |
| 2021-12-31 | $750.36M 20-F · filed 2022-04-29 | |
| 2020-12-31 | $818.95M 20-F · filed 2021-04-28 | |
| 2020-09-30 | $472.54M 6-K · filed 2021-02-05 | |
| 2019-12-31 | $195.54M 20-F · filed 2020-04-29 |